The Accelerating Solutions for Cell and Gene Therapy Evaluation and Novel Delivery (ASCEND) was created to coordinate and accelerate cell and gene therapy clinical trials at CU Anschutz. Gates Institu...

Senate budget bill includes small increase for the health-research agency — but faces a long road before being signed into law.

NCI funding policy for research project grant (RPG) awards reflects the funding goals of the institute, NIH, and HHS.

Maria Amaya, MD, PhD, University of Colorado Anschutz Medical Campus, Aurora, CO, presents the results from a clinical study (NCT05287568)...

Four CU Cancer Center members have been tapped to serve as ambassadors for its four main scientific and clinical research programs.

An international study led by the CU Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn’t work for everyone.

This Viewpoint discusses the critical importance of continued funding for the intramural research program in the Department of Veterans Affairs.

Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard

Manali Kamdar, MD, has transformed lymphoma care with groundbreaking chemo-free therapies, leading to improved patient outcomes and FDA-approved therapies.

In this issue of Blood, Liu et al1 report the results of a phase 1 clinical trial using pegcrisantaspase (PegC) in combination with venetoclax in relapsed

Alt: a man in a striped shirt is talking to another man and says did we just become best friends ?

Analysis of exomes and transcriptomes from 100 African American patients with acute myeloid leukemia identifies ancestry-related variation in mutation profiles and survival. Refined risk classificatio...